Soong R - Search Results

1

Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy.

Soo RA, Kawaguchi T, Loh M, Ou SH, Shieh MP, Cho BC, Mok TS, Soong R. Soo RA, et al. Among authors: soong r. Future Oncol. 2012 Apr;8(4):451-62. doi: 10.2217/fon.12.25. Future Oncol. 2012. PMID: 22515448 Review.

2

Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials.

Soo RA, Loh M, Mok TS, Ou SH, Cho BC, Yeo WL, Tenen DG, Soong R. Soo RA, et al. Among authors: soong r. J Thorac Oncol. 2011 Jun;6(6):1030-8. doi: 10.1097/JTO.0b013e3182199c03. J Thorac Oncol. 2011. PMID: 21532500 Free article. Review.

3

Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients.

Chuah B, Goh BC, Lee SC, Soong R, Lau F, Mulay M, Dinolfo M, Lim SE, Soo R, Furuie T, Saito K, Zergebel C, Rosen LS. Chuah B, et al. Among authors: soong r. Cancer Sci. 2011 Feb;102(2):478-83. doi: 10.1111/j.1349-7006.2010.01793.x. Epub 2010 Dec 10. Cancer Sci. 2011. PMID: 21143703 Free article.

4

Challenges and pitfalls in the introduction of pharmacogenetics for cancer.

Loh M, Soong R. Loh M, et al. Among authors: soong r. Ann Acad Med Singap. 2011 Aug;40(8):369-74. Ann Acad Med Singap. 2011. PMID: 22065003 Free article.

5

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer.

Chin LP, Soo RA, Soong R, Ou SH. Chin LP, et al. Among authors: soong r. J Thorac Oncol. 2012 Nov;7(11):1625-30. doi: 10.1097/JTO.0b013e31826baf83. J Thorac Oncol. 2012. PMID: 23070242 Free article. Review.

6

Immunotherapy in the treatment of non-small cell lung cancer.

Sundar R, Soong R, Cho BC, Brahmer JR, Soo RA. Sundar R, et al. Among authors: soong r. Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14. Lung Cancer. 2014. PMID: 24880938 Free PMC article. Review.

7

Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer.

Soo RA, Kim HR, Asuncion BR, Fazreen Z, Omar MFM, Herrera MC, Yun Lim JS, Sia G, Soong R, Cho BC. Soo RA, et al. Among authors: soong r. Lung Cancer. 2017 Mar;105:17-22. doi: 10.1016/j.lungcan.2017.01.008. Epub 2017 Jan 15. Lung Cancer. 2017. PMID: 28236980

8

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.

Soo RA, Lim SM, Syn NL, Teng R, Soong R, Mok TSK, Cho BC. Soo RA, et al. Among authors: soong r. Lung Cancer. 2018 Jan;115:12-20. doi: 10.1016/j.lungcan.2017.11.009. Epub 2017 Nov 13. Lung Cancer. 2018. PMID: 29290252 Review.

9

Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.

Soo RA, Wang LZ, Ng SS, Chong PY, Yong WP, Lee SC, Liu JJ, Choo TB, Tham LS, Lee HS, Goh BC, Soong R. Soo RA, et al. Among authors: soong r. Lung Cancer. 2009 Jan;63(1):121-7. doi: 10.1016/j.lungcan.2008.04.010. Epub 2008 Jun 5. Lung Cancer. 2009. PMID: 18538445

10

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?

Loh M, Chua D, Yao Y, Soo RA, Garrett K, Zeps N, Platell C, Minamoto T, Kawakami K, Iacopetta B, Soong R. Loh M, et al. Among authors: soong r. Pharmacogenomics J. 2013 Oct;13(5):423-9. doi: 10.1038/tpj.2012.26. Epub 2012 Jun 26. Pharmacogenomics J. 2013. PMID: 22733238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters